Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

Trial Profile

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CRD 102 (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Sponsors Cardiora
  • Most Recent Events

    • 24 Jun 2019 Status changed from recruiting to completed.
    • 06 Apr 2019 Results (n=6) presented at the 39th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 04 Feb 2019 Planned End Date changed from 1 Aug 2018 to 1 May 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top